Sanofi, Regeneron Get FDA Approval for Dupixent to Treat Rare Skin Disease

  • The Food and Drug Administration approved the drug for adult patients with bullous pemphigoid, which mainly affects the elderly and is characterized by itchiness, blisters and lesions.